KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Boston Scientific (BSX) Net Income towards Common Stockholders (2016 - 2026)

Boston Scientific's Net Income towards Common Stockholders history spans 18 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 98.96% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.6 billion, a 75.44% increase, with the full-year FY2025 number at $2.9 billion, up 56.4% from a year prior.
  • Net Income towards Common Stockholders hit $1.3 billion in Q1 2026 for Boston Scientific, up from $672.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for BSX hit a ceiling of $1.3 billion in Q1 2026 and a floor of $97.0 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged $488.6 million across 5 years, with a median of $495.0 million in 2024.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 70.34% in 2022 and later skyrocketed 300.79% in 2023.
  • Tracing BSX's Net Income towards Common Stockholders over 5 years: stood at $126.0 million in 2022, then skyrocketed by 300.79% to $505.0 million in 2023, then rose by 11.88% to $565.0 million in 2024, then increased by 18.94% to $672.0 million in 2025, then soared by 99.55% to $1.3 billion in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for BSX at $1.3 billion in Q1 2026, $672.0 million in Q4 2025, and $755.0 million in Q3 2025.